High Infectious Diseases Incidence Drives the Indian Anti-Infective Pharmaceutical Market, Finds Netscribes
Netscribes (India) Pvt. Ltd., launches a report on the Anti-Infective Pharmaceuticals Market in India 2011, as part of Netscribes’ Healthcare Industry report series.
Mumbai, India, March 17, 2012 --(PR.com)-- Netscribes (India) Pvt. Ltd., a knowledge consulting solutions company, announces the launch of its Anti-Infective Pharmaceuticals Market in India 2011 report. India, with its huge patient base, is expected to show steady growth over the coming years.
The report begins with the introduction section which offers a brief classification of the anti infectives market. It then moves to the market overview section which provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth.
An analysis of the drivers explains the factors for growth of the industry including increasing patient population, increasing vaccine approvals, increase in health insurances and introduction of newer and better drugs. The key challenges include pricing pressure and logistic problems in the vaccine market.
The government initiatives section gives a brief description of the different control programmes undertaken by the Government. It also analyses the efforts to reduce drug prices, changes in the customs duty structure and the various PPP projects undertaken by the Government.
A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals for anti infective drugs.
The competition section provides an overview of the competitive landscape in the industry. It includes a brief profile of the major players in the market along with their financials. It also includes the latest developments in the industry.
For more details on the content of each report and ordering information please contact:
Tamojit Roy
Tel: +91 33 4064 6215
Email: tamojit.roy@netscribes.com
The report begins with the introduction section which offers a brief classification of the anti infectives market. It then moves to the market overview section which provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth.
An analysis of the drivers explains the factors for growth of the industry including increasing patient population, increasing vaccine approvals, increase in health insurances and introduction of newer and better drugs. The key challenges include pricing pressure and logistic problems in the vaccine market.
The government initiatives section gives a brief description of the different control programmes undertaken by the Government. It also analyses the efforts to reduce drug prices, changes in the customs duty structure and the various PPP projects undertaken by the Government.
A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals for anti infective drugs.
The competition section provides an overview of the competitive landscape in the industry. It includes a brief profile of the major players in the market along with their financials. It also includes the latest developments in the industry.
For more details on the content of each report and ordering information please contact:
Tamojit Roy
Tel: +91 33 4064 6215
Email: tamojit.roy@netscribes.com
Contact
Netscribes India Pvt Ltd
Kalyan Banga
91 3340646215
netscribes.com
Kalyan Banga
91 3340646215
netscribes.com
Contact
Categories